Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.29% |
AMGEN INC. | AMGN | 5.32% |
GILEAD SCIENCES, INC. | GILD | 5.12% |
VERTEX PHARMACEUTICALS | VRTX | 4.30% |
ALNYLAM PHARMACEUTICALS | ALNY | 3.32% |
REGENERON PHARMACEUTICALS | REGN | 3.17% |
INSMED INC | INSM | 2.59% |
CORTEVA INC | CTVA | 2.42% |
ASTRAZENECA PLC ADR | AZN | 2.13% |
NATERA INC | NTRA | 2.02% |
BIOGEN IDEC, INC. | BIIB | 1.81% |
BEONE MEDICINES LTD-ADR | BGNE | 1.79% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.76% |
INCYTE CORP | INCY | 1.56% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.50% |
ILLUMINA INC | ILMN | 1.49% |
IONIS PHARMACEUTICALS, IN | IONS | 1.48% |
EXACT SCIENCES | EXAS | 1.43% |
ARGENX SE - ADR | ARGX | 1.42% |
VIATRIS INC | VTRS | 1.42% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.36% |
UNITED THERAPEUTICS CORP | UTHR | 1.34% |
CRISPR THERAPEUTICS AG | CRSP | 1.29% |
EXELIXIS, INC. | EXEL | 1.29% |
BRIDGEBIO PHARMA INC | BBIO | 1.29% |
REVOLUTION MEDICINES INC | RVMD | 1.27% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.26% |
GUARDANT HEALTH INC | GH | 1.24% |
MODERNA INC | MRNA | 1.22% |
ROIVANT SCIENCES LTD | ROIV | 1.19% |
ALKERMES PLC | ALKS | 1.15% |
AVIDITY BIOSCIENCES INC | RNA | 1.14% |
CYTOKINETICS INC | CYTK | 1.12% |
BIONTECH SE-ADR | BNTX | 1.08% |
VAXCYTE INC | PCVX | 1.07% |
HALOZYME THERAPEUTICS INC | HALO | 1.05% |
PROTAGONIST THER | PTGX | 1.01% |
ARROWHEAD PHARMACEUTICALS | ARWR | 1.00% |
INTELLIA THERAPE | NTLA | 0.97% |
LEGEND BIOTECH CORP-ADR | LEGN | 0.96% |
AXSOME THERAPEUT | AXSM | 0.95% |
PTC THERAPEUTICS | PTCT | 0.95% |
TG THERAPEUTICS | TGTX | 0.94% |
CRINETICS PHARMACEUTICALS | CRNX | 0.91% |
AKERO THERAPEUTICS INC | AKRO | 0.90% |
VIKING THERAPEUTICS INC | VKTX | 0.90% |
NUVALENT INC-A | NUVL | 0.89% |
MEDPACE HOLDINGS | MEDP | 0.74% |
ULTRAGENYX PHARM | RARE | 0.73% |
VERACYTE INC | VCYT | 0.72% |
ADMA BIOLOGICS INC | ADMA | 0.70% |
IDEAYA BIOSCIENCES INC | IDYA | 0.70% |
RECURSION PHARMACEUTICALS | RXRX | 0.67% |
APELLIS PHARMACE | APLS | 0.67% |
SUMMIT THERAPEUTICS INC | SMMT | 0.67% |
BEAM THERAPEUTICS INC | BEAM | 0.67% |
DYNE THERAPEUTICS INC | DYN | 0.66% |
SAREPTA THERAPEU | SRPT | 0.65% |
ARCELLX INC | ACLX | 0.65% |
AMICUS THERAPEUTICS INC | FOLD | 0.64% |
AGIOS PHARMACEUT | AGIO | 0.62% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.61% |
DENALI THERAPEUT | DNLI | 0.60% |
CELLDEX THERAPEUTICS INC | CLDX | 0.56% |
TWIST BIOSCIENCE CORP | TWST | 0.54% |
ASCENDIS PHA-ADR | ASND | 0.54% |
MADRIGAL PHARMAC | MDGL | 0.53% |
SOLENO THERAPEUTICS INC | SLNO | 0.49% |
IMMUNOVANT INC | IMVT | 0.47% |
KRYSTAL BIOTECH INC | KRYS | 0.46% |
NOVAVAX INC | NVAX | 0.45% |
DYNAVAX TECHNOLOGY | DVAX | 0.44% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.19% |
Other (Cash, derivatives and other liabilities) | 0.55% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.